Validating this original concept, we previously demonstrated that PGD - derived hES cells and their derivatives, which express the causal mutation implicated in the Myotonic Dystrophy type 1 (DM1), offer pertinent disease - cell models, applicable for a wide
systemic mechanistic analysis ranging from functional studies at the cellular level to a large - scale drug screening.